Light-Independent M1 Macrophage Polarization by Photosensitizer-Loaded Protein Corona on Gold Nanorods

References

• Wynn TA , ChawlaA, PollardJW. Macrophage biology in development, homeostasis and disease. Nature496(7446), 445–455 (2013).
   PubMed Web of Science ®Google Scholar
• Martinez FO , GordonS. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep.6, 1–13 (2014).
   PubMedGoogle Scholar
• Sica A , MantovaniA. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest.122(3), 787–795 (2012).
   PubMed Web of Science ®Google Scholar
• Italiani P , BoraschiD. From Monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol.5, 514 (2014).
   PubMed Web of Science ®Google Scholar
• Takeya M , KomoharaY. Role of tumor-associated macrophages in human malignancies: friend or foe?Pathol. Int.66(9), 491–505 (2016).
   PubMed Web of Science ®Google Scholar
• Ao JY , ZhuXD, ChaiZTet al. Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma. Mol. Cancer Ther.16(8), 1544–1554 (2017).
   PubMed Web of Science ®Google Scholar
• Solinas G , BecattiniB. The role of PI3Kγ in metabolism and macrophage activation. Oncotarget8(63), 106145–106146 (2017).
   PubMedGoogle Scholar
• Halama N , ZoernigI, BerthelAet al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell.29(4), 587–601 (2016).
   PubMed Web of Science ®Google Scholar
• Beatty GL , ChioreanEG, FishmanMPet al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science331(6024), 1612–1616 (2011).
   PubMed Web of Science ®Google Scholar
• Gordon SR , MauteRL, DulkenBWet al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature545(7655), 495–499 (2017).
   PubMed Web of Science ®Google Scholar
• Bartneck M , RitzT, KeulHAet al. Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano.6(10), 8767–8777 (2012).
   PubMed Web of Science ®Google Scholar
• Chakraborty P , ChatterjeeS, GangulyAet al. Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate. J. Leukoc. Biol.91(4), 609–619 (2012).
   PubMed Web of Science ®Google Scholar
• Zanganeh S , HutterG, SpitlerRet al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat. Nanotechnol.11(11), 986–994 (2016).
   PubMed Web of Science ®Google Scholar
• Miao X , LengX, ZhangQ. The current state of nanoparticle-induced macrophage polarization and reprogramming research. Int. J. Mol. Sci.18(2), 336 (2017).
   PubMed Web of Science ®Google Scholar
• Nishanth RP , JyotsnaRG, SchlagerJJet al. Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFκB signaling pathway. Nanotoxicology5(4), 502–516 (2011).
   PubMed Web of Science ®Google Scholar
• Yen H , HsuS, TsaiC. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small5(13), 1553–1561 (2009).
   PubMed Web of Science ®Google Scholar
• Li D , ZhangM, XuFet al. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation. Acta Pharm. Sin. B.8(1), 74–84 (2018).
   PubMed Web of Science ®Google Scholar
• Lu C , WeiY, XingD. Phototherapy-treated apoptotic tumor cells induce pro-inflammatory cytokines production in macrophage. Proc. SPIE 9230, Twelfth International Conference on Photonics and Imaging in Biology and Medicine (PIBM 2014).92301C (2014).
   Google Scholar
• Huang Y , MeiC, TianYet al. Bioinspired tumor-homing nanosystem for precise cancer therapy via reprogramming of tumor-associated macrophages. NPG Asia Mater.10, 1002–1015 (2018).
   Web of Science ®Google Scholar
• Yang Y , HuY, WangH. Targeting antitumor immune response for enhancing the efficacy of photodynamic therapy of cancer: recent advances and future perspectives. Oxid. Med. Cell Longev.2016, 5274084 (2016).
   PubMed Web of Science ®Google Scholar
• Lu C , ZhouF, WuSet al. Phototherapy-induced antitumor immunity: long-term tumor suppression effects via photoinactivation of respiratory chain oxidase-triggered superoxide anion burst. Antioxid Redox Signal.24(5), 249–262 (2016).
   PubMed Web of Science ®Google Scholar
• Yeo EL , CheahJU, NeoDJet al. Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy. J. Mater. Chem.5(2), 254–268 (2017).
   Web of Science ®Google Scholar
• Yeo EL , ThongPS, SooKCet al. Protein corona in drug delivery for multimodal cancer therapy in vivo. Nanoscale10(5), 2461–2472 (2018).
   PubMed Web of Science ®Google Scholar
• Borri C , CentiS, RattoFet al. Polylysine as a functional biopolymer to couple gold nanorods to tumor-tropic cells. J. Biotechnology16(1), 1–10 (2018).
   Google Scholar
• Ratto F , CentiS, AvigoCet al. A robust design for cellular vehicles of gold nanorods for multimodal imaging. Adv. Funct. Mater.26(39), 7178–7185 (2016).
   Web of Science ®Google Scholar
• Dai T , HuangYY, HamblinMR. Photodynamic therapy for localized infections – state of the art. Photodiagnosis Photodyn. Ther.6(3-4), 170–188 (2009).
   PubMed Web of Science ®Google Scholar
• Kah JC , ZubietaA, SaavedraRAet al. Stability of gold nanorods passivated with amphiphilic ligands. Langmuir28(24), 8834–8844 (2012).
   PubMed Web of Science ®Google Scholar
• Anger P , BharadwajP, NovotnyL. Enhancement and quenching of single-molecule fluorescence. Phys. Rev. Lett.96(11), 113002 (2006).
   PubMed Web of Science ®Google Scholar
• Maeß MB , WittigB, CignarellaAet al. Reduced PMA enhances the responsiveness of transfected THP-1 macrophages to polarizing stimuli. J. Immunol. Methods.402(1-2), 76–81 (2014).
   PubMed Web of Science ®Google Scholar
• Hu X , IvashkivLB. Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity31(4), 539–550 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen G , HercusT, WoodcockJet al. Structure of the GM-CSF receptor complex. Cell134(3), 496–507 (2008).
   PubMed Web of Science ®Google Scholar
• Genin M , ClementF, FattaccioliAet al. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer.15(1), 577 (2015).
   PubMedGoogle Scholar
• Nau GJ , RichmondJF, SchlesingerAet al. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl Acad. Sci. USA99(3), 1503–1508 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang M , WangX, WangYet al. IL-4/IL-13–mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int.91(2), 375–386 (2017).
   PubMed Web of Science ®Google Scholar
• Engström A , ErlandssonA, DelbroDet al. Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2. Int. J. Oncol.44(2), 385–392 (2013).
   PubMed Web of Science ®Google Scholar
• De Puig H , BoschI, Carré-CampsMet al. Effect of the protein corona on antibody–antigen binding in nanoparticle sandwich immunoassays. Bioconjug. Chem.28(1), 230–238 (2017).
   PubMed Web of Science ®Google Scholar
• Alkilany A , MurphyC. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?J. Nanopart Res.12(7), 2313–2333 (2010).
   PubMed Web of Science ®Google Scholar
• Yu Q , ZhaoL, GuoCet al. Regulating protein corona formation and dynamic protein exchange by controlling nanoparticle hydrophobicity. Front. Bioeng. Biotechnol.8, 210 (2020).
   PubMed Web of Science ®Google Scholar
• Rőszer T . Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm.2015, 816460 (2015).
   PubMed Web of Science ®Google Scholar
• Parameswaran N , PatialS. Tumor necrosis factor-α signaling in macrophages. Crit. Rev. Eukaryot. Gene Expr.20(2), 87–103 (2011).
   Web of Science ®Google Scholar
• Lopez-Castejon G , BroughD. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev.22(4), 189–195 (2011).
   PubMed Web of Science ®Google Scholar
• Tanaka T , NarazakiM, KishimotoT. IL-6 in inflammation, immunity and disease. Cold Spring Harb. Perspect. Biol.6(10), a016295 (2014).
   PubMed Web of Science ®Google Scholar
• Scodeller P , Simón-GraciaL, KopanchukSet al. Precision targeting of tumor macrophages with a CD206 binding peptide. Sci. Rep.7, 14655 (2017).
   PubMed Web of Science ®Google Scholar
• Lugo-Villarino G , TroegelerA, BalboaLet al. The C-Type lectin receptor DC-SIGN has an anti-Inflammatory role in human M(IL-4) macrophages in response to mycobacterium tuberculosis. Front. Immunol.9, 1123 (2018).
   PubMed Web of Science ®Google Scholar
• Rong C , JiayuR, YingluJet al. Corona of thorns: the surface chemistry-mediated protein corona perturbs the recognition and immune response of macrophages. ACS Appl. Mater. Interfaces.12(2), 1997–2008 (2020).
   PubMed Web of Science ®Google Scholar
• Gustafson HH , Holt-CasperD, GraingerDWet al. Nanoparticle uptake: the phagocyte problem. Nanotoday10(4), 487–510 (2015).
   Google Scholar
• Verma A , StellacciF. Effect of surface properties on nanoparticle–cell interactions. Small6(1), 12–21 (2016).
   Google Scholar
• Cho EC , AuL, ZhangQet al. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small6(4), 517–522 (2010).
   PubMed Web of Science ®Google Scholar
• Choi M , Stanton-MaxeyKJ, StanleyJKet al. A cellular trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett.7(12), 3759–3765 (2007).
   PubMed Web of Science ®Google Scholar
• Li S , FengS, DingLet al. Nanomedicine engulfed by macrophages for targeted tumor therapy. Int. J. Nanomedicine11, 4107–4124 (2016).
   PubMed Web of Science ®Google Scholar
• Ahn S , SeoE, KimKet al. Controlled cellular uptake and drug efficacy of nanotherapeutics. Sci. Rep.3, 1997 (2013).
   PubMed Web of Science ®Google Scholar
• Figueiredo RT , FernandezPL, Mourao-SaDSet al. Characterization of heme as activator of toll-like receptor 4. J. Biol. Chem.282(2), 20221–20229 (2007).
   PubMedGoogle Scholar
• Wang X , YongL. Tumor necrosis factor and cancer, buddies or foes?Acta Pharm. Sin.29(11), 1275–1288 (2009).
   Web of Science ®Google Scholar
• Aggarwal BB . Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol.3(9), 745–756 (2003).
   PubMed Web of Science ®Google Scholar
• Apte RN , VoronovE. Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?Immunol. Rev.222(1), 222–241 (2008).
   PubMedGoogle Scholar